515 related articles for article (PubMed ID: 35513543)
1. Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43.
Tarutani A; Adachi T; Akatsu H; Hashizume Y; Hasegawa K; Saito Y; Robinson AC; Mann DMA; Yoshida M; Murayama S; Hasegawa M
Acta Neuropathol; 2022 Jun; 143(6):613-640. PubMed ID: 35513543
[TBL] [Abstract][Full Text] [Related]
2. Experimental models of prion-like protein propagation.
Hasegawa M
Neuropathology; 2020 Oct; 40(5):460-466. PubMed ID: 32478452
[TBL] [Abstract][Full Text] [Related]
3. Prion-like properties of assembled TDP-43.
Nonaka T; Hasegawa M
Curr Opin Neurobiol; 2020 Apr; 61():23-28. PubMed ID: 31862626
[TBL] [Abstract][Full Text] [Related]
4. Prion-like mechanisms in neurodegenerative diseases.
Frost B; Diamond MI
Nat Rev Neurosci; 2010 Mar; 11(3):155-9. PubMed ID: 20029438
[TBL] [Abstract][Full Text] [Related]
5. Prion-like propagation of α-synuclein in neurodegenerative diseases.
Tarutani A; Hasegawa M
Prog Mol Biol Transl Sci; 2019; 168():323-348. PubMed ID: 31699325
[TBL] [Abstract][Full Text] [Related]
6. [The Prion-like Mechanism in Neurodegenerative Diseases-Current Studies and Future Prospects].
Tarutani A; Hisanaga SI; Hasegawa M
Brain Nerve; 2016 Oct; 68(10):1197-1204. PubMed ID: 27703107
[TBL] [Abstract][Full Text] [Related]
7. Structures of tau and α-synuclein filaments from brains of patients with neurodegenerative diseases.
Kametani F; Hasegawa M
Neurochem Int; 2022 Sep; 158():105362. PubMed ID: 35659527
[TBL] [Abstract][Full Text] [Related]
8. Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders.
Hasegawa M; Nonaka T; Masuda-Suzukake M
Pharmacol Ther; 2017 Apr; 172():22-33. PubMed ID: 27916654
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of the co-deposition of multiple pathological proteins in neurodegenerative diseases.
Nonaka T; Masuda-Suzukake M; Hasegawa M
Neuropathology; 2018 Feb; 38(1):64-71. PubMed ID: 28948653
[TBL] [Abstract][Full Text] [Related]
10. Pathological alpha-synuclein propagates through neural networks.
Masuda-Suzukake M; Nonaka T; Hosokawa M; Kubo M; Shimozawa A; Akiyama H; Hasegawa M
Acta Neuropathol Commun; 2014 Aug; 2():88. PubMed ID: 25095794
[TBL] [Abstract][Full Text] [Related]
11. [Pathology of basal ganglia in neurodegenerative diseases].
Wakabayashi K; Tanji K; Mori F
Brain Nerve; 2009 Apr; 61(4):429-39. PubMed ID: 19378813
[TBL] [Abstract][Full Text] [Related]
12. [The Propagation Hypothesis of Prion-like Protein Agregates in Neurodegenerative Diseases].
Nonaka T
Brain Nerve; 2019 Nov; 71(11):1209-1214. PubMed ID: 31722306
[TBL] [Abstract][Full Text] [Related]
13. Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods.
Tarutani A; Arai T; Murayama S; Hisanaga SI; Hasegawa M
Acta Neuropathol Commun; 2018 Apr; 6(1):29. PubMed ID: 29669601
[TBL] [Abstract][Full Text] [Related]
14. Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.
Goedert M; Masuda-Suzukake M; Falcon B
Brain; 2017 Feb; 140(2):266-278. PubMed ID: 27658420
[TBL] [Abstract][Full Text] [Related]
15. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Marcilla I; Marti-Andres G; Caballero MC; Riverol M; Tuñon MT; Fraser PE; Luquin MR
Acta Neuropathol Commun; 2021 Apr; 9(1):64. PubMed ID: 33832546
[TBL] [Abstract][Full Text] [Related]
16. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
17. The expanding realm of prion phenomena in neurodegenerative disease.
Frost B; Diamond MI
Prion; 2009; 3(2):74-7. PubMed ID: 19448400
[TBL] [Abstract][Full Text] [Related]
18. The role of crowded physiological environments in prion and prion-like protein aggregation.
Ma Q; Hu JY; Chen J; Liang Y
Int J Mol Sci; 2013 Oct; 14(11):21339-52. PubMed ID: 24284393
[TBL] [Abstract][Full Text] [Related]
19. Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration.
Scialò C; De Cecco E; Manganotti P; Legname G
Viruses; 2019 Mar; 11(3):. PubMed ID: 30875755
[TBL] [Abstract][Full Text] [Related]
20. Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics.
Kovacs GG; Botond G; Budka H
Acta Neuropathol; 2010 Apr; 119(4):389-408. PubMed ID: 20198481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
